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Abstract 
Objective: To review new incidental findings detected on low-resolution CT 
attenuation correction (CTAC) images acquired during SPECT-CT myocardial 
perfusion imaging (MPI) as an extension to our initial study. 
 
Methods: CTAC images acquired as part of MPI performed using SPECT at four UK 
nuclear medicine centres were evaluated as part of a multi-centre study.  New 
incidental findings that were considered to be clinically significant were evaluated 
further.  Positive predictive value (PPV) was determined at the time of definitive 
diagnosis. 
Results: Out of 3485 patients, 962 (28%) had a positive finding on the CTAC image, 
of which 824 (24%) were new findings. Eighty four (2.4%) patients had findings that 
were considered clinically significant at the time of the CTAC report and which had 
not been previously diagnosed.  However, only 10 (0.29%) of these had findings that 
were confirmed as clinically significant, with the potential to be detrimental to patient 
outcome, after follow-up and definitive diagnosis. 
Conclusion: The overall PPV from all centres over the two-year period was 12%.  
Each centre achieved what we considered to be low PPVs with no significant 
difference between current and initial studies. The additional data from the combined 
studies shows that, statistically, there is no significant difference between the PPVs 
from any of the centres.  We conclude that routine reporting of CTAC images is not 
beneficial.   
 
 
Advances in knowledge: This study and the previous study combined, offer a unique 
evaluation of new clinically significant incidental findings on low-resolution CT 
images in an attempt to determine the benefit of reporting the CTAC images.  
 
Introduction 
CT attenuation correction (CTAC) is frequently used to correct single-photon 
emission computed tomography (SPECT) images during myocardial perfusion 
imaging (MPI) 1,2.  A low-dose CT acquisition is performed through the area of the 
heart to match the range of the SPECT scan. Although the CT is performed for AC 
purposes only, a by-product of the process is the availability of low-resolution CT 
images of part of the chest.  It is known that these images can demonstrate 
incidental findings3,4but what is currently unknown is the significance of these 
findings.       
 
Previously we have reported on a one-year study which reviewed the CTAC images 
from SPECT MPI from four nuclear medicine centres.5 This initial study revealed 
varied results.  Out of 1819 patients studied 497 (27%) had a positive finding of 
which 423 (23%) were new findings.  Fifty-one (2.8%) patients had findings that were 
considered clinically significant at the time of the CTAC report and which had not 
been previously diagnosed.  However, only 4 (0.2%) of these findings had the 
potential to be detrimental to patient outcome.  For the four centres, the overall 
positive predictive value (PPV) was 8%.  However, the PPV from the individual 
centres varied from 0% to 67% and this was thought to be due to the varying image 
qualities produced by the different specification CT scanners utilised across the 
centres.  The initial study concluded that further research was needed to establish 
the actual diagnostic value of CT used for AC in MPI, especially in the case of the 
medium resolution CT sub-systems.5 Therefore, a further year’s data has now been 
evaluated in this current study. 
 
Objective: 
 To review the new incidental findings, from a multi-centre study, that were detected 
on low-resolution CTAC images acquired during SPECT-CT MPI that were 
considered to be clinically significant at the time of reporting.  The results will be 
compared to, and combined with, the results from our initial study to give data over a 
2 year study period. 
 
Methods and Materials 
The current multi-centre study was carried out in the same four UK nuclear medicine 
centres, using the same method as our initial study5. During a further period of one 
year, data from an additional 1666 patients were collected. The low-resolution CTAC 
images acquired as part of SPECT MPI studies were evaluated and the number of 
incidental findings was determined.  
 
The CTAC images were reviewed on a variety of CT window settings to demonstrate 
lung, bone and soft tissue.  For consistency, the images were evaluated and 
reported by the same four consultant radiologists as in our initial study.  The 
radiologists used a proforma informed by guidance from the Royal College of 
Radiologists6 to structure the written reports.  Each report stated that the images 
were from a low-resolution/low quality CT that had been performed as part of a 
nuclear medicine MPI study and, as such, it was clear to referring clinicians that the 
images were not meant for diagnosis. 
 
Approval was gained locally from each participating hospital as either service 
evaluation or audit.  Ethical approval was obtained from the University of Salford. 
The CT scan parameters of the SPECT-CT equipment used in each centre are 
shown in table 1.   
 
Table 1 - Scan Parameters of the SPECT-CT Systems 
 
Image Evaluation 
The CTAC images from the additional 1666 patients in the current study were 
evaluated in the same manner as in the initial study.  Where both stress and rest 
studies were performed, it was considered to be one examination.  Only written 
reports which included previously unknown pathology were included in the final 
evaluation and these findings were described as being new positive findings. New 
positive findings were classified according to the clinical significance at the time of 
report.  The classification system was adapted from the one used by Goetze et al 
(2006)7 and is shown in table 2.  
 
Table 2 - Classification of Findings 
 
Findings that were classified as major were considered to be clinically significant.  
Every major finding was followed-up by the hospital concerned as they could 
potentially affect the clinical management of the patient.  These patients were 
subsequently followed up with diagnostic imaging or interventional procedures for a 
period of up to 2 years or until a definitive diagnosis was made.5   All other findings 
were considered to be insignificant and have not been included in our analysis. 
 
The positive predictive values (PPVs) of the CTAC images for patients with clinically 
significant new positive findings from each centre were determined.   These were 
then compared with the PPVs from the results of our initial study.5  
 
The PPV was calculated at the time of the definitive diagnosis rather than at the time 
of the CTAC report.  Therefore, PPV was calculated as the percentage of new 
significant findings that ultimately could affect patient outcome.                                             
 
Results 
Table 3 summarises the findings of the current study.  Out of 1666 patients, 465 
(28%) had a positive finding, of which 401 (24%) were new findings.  Thirty-three 
patients (2%) had findings that were considered clinically significant at the time of the 
CTAC report and which had not been diagnosed previously.  However, only 6 
(0.36%) of these had findings that were confirmed as significant, with the potential to 
be detrimental to patient outcome, when a definitive diagnosis was made. 
 
Table 3 - Number of Incidental CTAC Findings in the current Study 
 
 
 
 
 
 
 
 
Discussion 
 
When data from our initial study5 are combined with the current study, a total of 3485 
patients were included.  Of these, 962 (28%) had a positive finding on the CTAC 
image, of which 824 (24%) were new findings. Eighty four (2.4%) patients had 
findings that were considered clinically significant at the time of the CTAC report and 
which had not been diagnosed previously.  However, only 10 (0.29%) of these had 
findings that were confirmed as clinically significant, with the potential to be 
detrimental to patient outcome, after follow-up and definitive diagnosis. 
 
We can now compare results of the current and initial studies. In the current study, at 
the time of the radiological CTAC report, 33/1666 (2%) were considered to have new 
clinically significant findings, but after follow-up only 6 patients (0.36%) had 
confirmed clinical findings that were considered to be detrimental to patient outcome.  
This compared with a rate of confirmed positive findings of 4/1819 (0.22%) that were 
detrimental to patient outcome in our initial study.5 The difference between the initial 
and current study was not significant (p=0.53, Fisher’s exact test). The overall rate of 
confirmed positive findings from our initial and current studies combined was 
10/3485 (0.29%). 
 
Of the 33 (2%) patients who were followed up in the current study as a result of 
having clinically significant findings at the time of the CTAC report, 27 (1.64%) did 
not have significant findings confirmed.  An example of this can be seen below in 
Figure 1.  A solid lesion was reported in the patient’s right breast that was suspicious 
of malignant pathology.  Whilst appearance on CT was that of a solid lesion, the 
definitive diagnosis was a benign cyst. 
 Figure 1 – breast lesion that appeared solid on CT but was a benign cyst 
 
 
 
 
Table 4 illustrates the individual and total PPVs and the confirmed positive rates from 
the current, initial and combined studies.  In the current study there was an overall 
PPV of 18% when all four centres were combined.  Statistically this was not 
significantly different to the overall PPV of the initial study (p=0.18 using Fisher’s 
exact test). The PPVs at the individual centres varied.  
 
Table 4 – Positive Predictive Values and Confirmed Positive Rates of the Initial, 
Current, and Combined Studies 
 
 
The PPV at centre 1, which used a GE Infinia with Hawkeye single slice CT, was 0% 
in the current study. This was consistent with the findings of the initial study.  There 
were no confirmed clinically significant findings at centre 1 and consequently CTAC 
images from this low specification CT scanner are no longer reported by this centre.  
 
The PPV at centre 2, which used a GE Infinia with Hawkeye 4 slice CT, was 25% in 
the current study. Of the 4 clinically significant findings reported at the time of CTAC 
imaging, only one of these was later confirmed as being detrimental to patient 
outcome; this was a lung cancer staged as T2 N1 M0.  One patient had a suspected 
hamartoma, a benign lesion, but the patient left the country prior to confirmation.  A 
further patient died before follow up and the medical notes were no longer available.  
The final patient had findings that resolved over time.  The PPV in the current study 
was not significantly different to the initial study PPV of 6% (p=0.31 using Fisher’s 
exact test). The overall PPV from the combined data from this centre was 9%.  
 
The PPV at centre 3, which also used a GE Infinia with Hawkeye 4 slice CT, was 
27%.  Of the 11 patients who had significant clinical findings at the time of the CTAC 
report, 3 were confirmed as being significant. One patient had a confirmed dilated 
ascending aorta with left ventricular outflow tract dilatation.  This patient 
subsequently received regular follow-up imaging.  Another patient had a hiatus 
hernia with both herniation of the stomach and splenic flexure of the colon that, 
subsequently, was repaired.  The third patient had a confirmed descending thoracic 
aortic aneurysm.  Although the two patients with aortic aneurysms had significant 
findings, it is not certain whether these patients were asymptomatic or whether they 
had symptoms related to the clinical indications for undergoing MPI.  In that sense, 
these two differ from other findings in the study that were true, asymptomatic 
incidental findings.  The PPV in the current study was not significantly different from 
the PPV of 0% in our initial study (p=0.51 using Fisher’s exact test).  The overall PPV 
from the combined data from this centre was 19%.  
 
The difference in PPV between centres 2 and 3, which both used the same 
equipment, is not significant (p=0.36 using Fisher’s exact test). The combined PPV 
for all data from these two centres was 12%. 
 
The PPV at centre 4, which used a Philips Precedence 16 slice CT system, was 
14%. Of the 14 patients who had significant clinical findings at the time of the CTAC 
report, 2 were confirmed as being significant.  One patient (Figure 2) was too 
unstable for biopsy but was diagnosed radiologically and clinically with lung cancer.  
The other patient was diagnosed with metastases from a primary uterine 
leiomyosarcoma.  Our initial study (PPV 67%) suggested that it might be beneficial to 
report the CTAC images produced at centre 4, which had been produced with 
acquisition parameters potentially leading to superior image quality.  However, 
although the initial study showed a higher PPV, this was not significantly different 
statistically to the current study (p=0.12 using Fisher’s exact test). The overall PPV 
for the combined data from centre 4 was 24% which was not significantly different to 
that from centres 2 and 3 combined (p=0.25 using Fisher’s exact test).  
 
 
 
 
Figure 2 – Clinical and radiological diagnosis of progressing lung cancer 
 
 
 
There was no significant change in the number of clinically significant findings 
between the initial and the current studies for centres 1 and 3.  Cenre 2 had a highly 
significant (0.001%) reduction in the number of clinically significant findings from 
31/1011 in the initial study to 4/870 in the current study. This could possibly reflect 
learning by experience of the reporter.  Centre 4 had a just significant increase 
(p=0.047) in rate of clinically significant findings from 3/211 in the initial study to 
14/299 in the current study.  This has, no doubt, had an impact on the PPV at this 
centre.  It is possible that this is related to an increase in confidence which has led to 
over-reporting.  It could also be due to the types of pathology in this study which 
have been classified as significant.  In the initial study, the 3 patients with confirmed 
significant findings either had lung nodules or lung cancers.  In this study, there were 
a number of pathologies that resolved over time.  This is potentially true of all the 
centres and could increase the number of false-positives identified. 
 
Our study has raised the question of what should be considered as an acceptable 
PPV for this type of examination. We have considered the combined PPV of 12% as 
being low. However, Nice guidance (2015)8 has published a reduction in threshold 
PPV from 4% to 3% for symptomatic patients attending primary care.  The patients in 
our study were non-symptomatic and their incidental findings had been detected as 
part of an unrelated cardiac study.  It is worth noting that cardiac diseases share 
certain risk factors with lung cancer and so it is likely that there would be a higher 
prevalence of lung cancer in these patients and so a higher PPV would be expected.  
Most importantly, these patients have findings that were unexpected or had false-
positive incidental findings that necessitated follow-up.  This is a very different 
situation than for patients who are being investigated for a disease for which they 
have related symptoms.  The psychological impact to patients receiving false-
positive unexpected results is unknown.   
 
Conclusion 
The overall PPV from all centres over the two-year period was 12%.  Each centre 
achieved what we considered to be low PPVs with no significant difference between 
current and initial studies. Results from the initial study demonstrated that there was 
no value reporting CTAC images from Centre 1.  The additional data from the 
combined studies shows that, statistically, there is no significant difference between 
the PPVs from any of the centres.  It would appear that Centre 4, which was initially 
thought to have a much higher PPV was actually performing at a similar level.   
 
Whilst the results revealed that 2.4% of findings were significant enough to warrant 
follow-up tests, only 0.29% were actually confirmed as having the potential to be 
detrimental to patient outcome.  We conclude that routine reporting of CTAC images 
is not beneficial.  Patient anxiety related to false-positive incidental findings is an 
area that the authors intend to consider in future work. 
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